1 New Reason to Buy Intuitive Surgical Stock and Hold Forever
Intuitive Surgical (NASDAQ: ISRG) has quite a few traits that make it a desirable stock to buy and hold for long periods. Aside from being a leader in the robotic surgery space, it's consistently profitable, and it has a clear roadmap to keep growing its revenue and earnings at a moderate pace for the foreseeable future.
There's little reason to doubt that it can execute on the same business plan that has carried the company to its present heights. In fact, there's now one more reason to buy the stock and hang on to it.
On March 14, the Food and Drug Administration (FDA) approved the fifth iteration of Intuitive's da Vinci surgical robotics suite. But this was far more than a few incremental improvements, and understanding why the launch constitutes a reason to buy the stock will require a little digging into the specifics of its features. While the company claims that the new edition has 150 updates and improvements, there are two that are particularly important in the context of its continued dominance in the robotic surgical space.
Source Fool.com
Vinci S.A. Aktie
Aktuell gibt es mit 0 Sell-Einschätzungen und 1 Buy-Einschätzungen noch kein wirkliches Sentiment für die Vinci S.A. Aktie.
Das Community-Kursziel von 120 € für Vinci S.A. deutet auf ein leicht positives Wachstumspotenzial gegenüber 111.1 € hin.
